Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation

다국어 초록 (Multilingual Abstract)

Tacrolimus is a widely used immunosuppressive agent for the prophylaxis of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation (HSCT). Since tacrolimus is primarily metabolized by the liver, hepatic dysfunction may affect its metabolism. Hepatic veno-occlusive disease (VOD) is an early complication of HSCT that results in hepatic dysfunction, suggesting that VOD may affect tacrolimus metabolism. We report a case of hepatic VOD accompanied by a sustained high blood trough level of tacrolimus despite its discontinuation. The findings of this case suggest that the elimination of tacrolimus can be markedly delayed in patients with hepatic VOD, and that the clinician should carefully modulate the drug dosage for these patients.

참고문헌 (Reference)

1 Boswell GW, "Tacrolimus pharmacokinetics in BMT patients" 21 : 23-28, 1998

2 Przepiorka D, "Practical considerations in the use of tacrolimus for allogeneic marrow transplantation" 24 : 1053-1056, 1999

3 Ratanatharathorn V, "Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation" 92 : 2303-2314, 1998

4 Jusko WJ, "Pharmacokinetics of tacrolimus in liver transplant patients" 57 : 281-290, 1995

5 Eidelman BH, "Neurologic complications of FK 506" 23 : 3175-3178, 1991

6 Iwasaki K, "Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics" 22 : 328-335, 2007

7 Kumar S, "Hepatic venoocclusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation" 78 : 589-598, 2003

8 Shulman HM, "Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules" 127 : 549-558, 1987

9 Jain AB, "Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations" 22 : 57-59, 1990

10 McLean AJ, "Clinical pharmacokinetics in patients with liver disease" 21 : 42-69, 1991

11 Staatz CE, "Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation" 43 : 623-653, 2004

12 Mori T, "Altered metabolism of tacrolimus in hepatic veno-occlusive disease" 18 : 1215-1217, 2005

13 Nieto Y, "Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation" 26 : 109-111, 2000